CPT Code: 92083 Region: 37
States covered: General guidelines if your state does not have a local coverage determination
Title: Visual Field Examination - Extended Intensity
Category
Special Ophthalmological Services
Description
Visual Field Examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30i, or quantitative automated threshold perimetry, Octopus Program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2)
Medicare does not have a local coverage determination (LCD) for a visual field examination, extended intensity. The policy presented is a sample and is provided as a reference guide only and should not be construed as policy for your current Medicare carrier.
Visual fields are examined by the use of static or kinetic perimetry. The procedure is performed separately for each eye and measures the combined function of the retina, the optic nerve and the intracranial visual pathway. It is used clinically to detect or monitor field loss due to disease at any of these locations. Visual fields may be determined by several methods including a tangent screen, Goldmann perimeter and computerized automated perimeters.
The visual field is the area within which objects may be seen when the eye is fixed. To standardize testing, several automated and computerized perimeters are available. However, manual perimeters are also utilized.
Visual field examinations may be considered medically necessary under any of the following conditions:
- The patient has inflammation or disorders of the eyelids potentially affecting the visual field
- The patient has a documented diagnosis of glaucoma (Please note that the stabilization or progression of glaucoma can be monitored only by a visual field examination, and the frequency of such examinations is dependent on the variability of intraocular pressure measurements (i.e., progressive increases despite treatment indicate a worsening condition), the appearance of new hemorrhages, and progressive cupping of the optic nerve)
- The patient is a glaucoma suspect as evidenced by an increase in intraocular pressure, asymmetric intraocular measurements of greater than 2-3 mm Hg between the two eyes, or has optic nerves suspicious for glaucoma which may be manifested as asymmetrical cupping, disc hemorrhage, or an absent or thinned temporal rim
- The patient has a documented disorder of the optic nerve, the neurologic visual pathway, or retina (Please note that patients with a previously diagnosed retinal detachment do not need a pretreatment visual field examination. Additionally, patients with an established diagnosed cataract do not need a follow-up visual field unless other presenting symptomatology is documented. In patients who are about to undergo cataract extraction, who do not have glaucoma and are not glaucoma suspects, a visual field would not be indicated)
- The patient has a recent intracranial hemorrhage, an intracranial mass or a recent measurement of increased intracranial pressure with or without visual symptomatology
- The patient has a recently documented occlusion or/and stenosis of cerebral and precerebral arteries, a recently diagnosed transient cerebral ischemia or giant cell arteritis
- The patient having an initial workup for buphthalmos, congenital anomalies of the posterior segment or congenital ptosis
- The patient has inflammation or disorders of the orbit, potentially affecting the visual field
- The patient has sustained a significant eye injury
- The patient has an unexplained visual loss which may be described as “trouble seeing or vision going in and out”
- The patient has a pale or swollen optic nerve documented by a visual exam of recent origin
- The patient is having some new functional limitations which may be due to visual field loss (i.e., reports by family that patient is running into things)
- The patient is being evaluated initially for macular degeneration or has experienced central vision loss resulting in vision measured at or below 20/70 (Please note that repeated examinations for a diagnosis of macular degeneration or an experienced central vision loss are not necessary unless changes in vision are documented or to evaluate the results of a surgical intervention)
- Repeat visual field examinations for patients undergoing surgery of the upper eyelid(s) and brow are considered reasonable and medically necessary. The initial (taped) and repeat (untaped) visual field examination should be performed on the same date of service.
- The patient is receiving or has completed treatment of a high-risk medication that may cause visual side effects, (i.e., a patient on plaquenil may develop retinopathy)
ICD-10 Diagnosis Codes
ICD-10 Codes | Description |
---|---|
A18.52 - A18.59 | Tuberculous keratitis - Other tuberculosis of eye |
A52.12 | Other cerebrospinal syphilis |
A52.14 - A52.15 | Late syphilitic encephalitis - Late syphilitic neuropathy |
A52.19 | Other symptomatic neurosyphilis |
A52.73 | Symptomatic late syphilis of other respiratory organs |
A52.76 | Other genitourinary symptomatic late syphilis |
A52.79 | Other symptomatic late syphilis |
B60.13 | Keratoconjunctivitis due to Acanthamoeba |
C69.00 - C69.92 | Malignant neoplasm of unspecified conjunctiva - Malignant neoplasm of unspecified site of left eye |
C70.0 | Malignant neoplasm of cerebral meninges |
C70.9 | Malignant neoplasm of meninges, unspecified |
C71.0 - C71.9 | Malignant neoplasm of cerebrum, except lobes and ventricles - Malignant neoplasm of brain, unspecified |
C72.20 - C72.59 | Malignant neoplasm of unspecified olfactory nerve - Malignant neoplasm of other cranial nerves |
C79.32 - C79.49 | Secondary malignant neoplasm of cerebral meninges - Secondary malignant neoplasm of other parts of nervous system |
D09.20 - D09.22 | Carcinoma in situ of unspecified eye - Carcinoma in situ of left eye |
D31.00 - D31.92 | Benign neoplasm of unspecified conjunctiva - Benign neoplasm of unspecified part of left eye |
D33.3 | Benign neoplasm of cranial nerves |
D35.2 - D35.3 | Benign neoplasm of pituitary gland - Benign neoplasm of craniopharyngeal duct |
D44.3 - D44.5 | Neoplasm of uncertain behavior of pituitary gland - Neoplasm of uncertain behavior of pineal gland |
D49.7 - D49.89 | Neoplasm of unspecified behavior of endocrine glands and other parts of nervous system - Neoplasm of unspecified behavior of other specified sites |
D57.00 - D57.219 | Hb-SS disease with crisis, unspecified - Sickle-cell/Hb-C disease with crisis, unspecified |
D57.80 - D57.819 | Other sickle-cell disorders without crisis - Other sickle-cell disorders with crisis, unspecified |
E05.00 - E05.11 | Thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm - Thyrotoxicosis with toxic single thyroid nodule with thyrotoxic crisis or storm |
E08.311 - E08.37X9 | Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy with macular edema - Diabetes mellitus due to underlying condition with diabetic macular edema, resolved following treatment, unspecified eye |
E09.311 - E09.37X9 | Drug or chemical induced diabetes mellitus with unspecified diabetic retinopathy with macular edema - Drug or chemical induced diabetes mellitus with diabetic macular edema, resolved following treatment, unspecified eye |
E10.311 - E10.39 | Type 1 diabetes mellitus with unspecified diabetic retinopathy with macular edema - Type 1 diabetes mellitus with other diabetic ophthalmic complication |
E11.311 - E11.39 | Type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema - Type 2 diabetes mellitus with other diabetic ophthalmic complication |
E13.311 - E13.39 | Other specified diabetes mellitus with unspecified diabetic retinopathy with macular edema - Other specified diabetes mellitus with other diabetic ophthalmic complication |
E34.1 | Other hypersecretion of intestinal hormones |
E34.8 | Other specified endocrine disorders |
E35 | Disorders of endocrine glands in diseases classified elsewhere |
E50.0 - E50.9 | Vitamin A deficiency with conjunctival xerosis - Vitamin A deficiency, unspecified |
E64.1 | Sequelae of vitamin A deficiency |
F44.4 - F44.7 | Conversion disorder with motor symptom or deficit - Conversion disorder with mixed symptom presentation |
G43.001 - G43.919 | Migraine without aura, not intractable, with status migrainosus - Migraine, unspecified, intractable, without status migrainosus |
G45.0 - G46.8 | Vertebro-basilar artery syndrome - Other vascular syndromes of brain in cerebrovascular diseases |
G93.2 | Benign intracranial hypertension |
H00.011 - H02.9 | Hordeolum externum right upper eyelid - Unspecified disorder of eyelid |
H05.00 - H05.9 | Unspecified acute inflammation of orbit - Unspecified disorder of orbit |
H16.001 - H16.9 | Unspecified corneal ulcer, right eye - Unspecified keratitis |
H17.00 - H17.9 | Adherent leukoma, unspecified eye - Unspecified corneal scar and opacity |
H18.001 - H22 | Unspecified corneal deposit, right eye - Disorders of iris and ciliary body in diseases classified elsewhere |
H25.011 - H26.9 | Cortical age-related cataract, right eye - Unspecified cataract |
H28 | Cataract in diseases classified elsewhere |
H30.001 - H35.09 | Unspecified focal chorioretinal inflammation, right eye - Other intraretinal microvascular abnormalities |
H35.171 - H35.469 | Retrolental fibroplasia, right eye - Secondary vitreoretinal degeneration, unspecified eye |
H35.51 - H35.54 | Vitreoretinal dystrophy - Dystrophies primarily involving the retinal pigment epithelium |
H35.60 - H35.9 | Retinal hemorrhage, unspecified eye - Unspecified retinal disorder |
H40.001 - H40.009 | Preglaucoma, unspecified, right eye - Preglaucoma, unspecified, unspecified eye |
H40.011 | Open angle with borderline findings, low risk, right eye |
H40.012 | Open angle with borderline findings, low risk, left eye |
H40.013 | Open angle with borderline findings, low risk, bilateral |
H40.021 | Open angle with borderline findings, high risk, right eye |
H40.022 | Open angle with borderline findings, high risk, left eye |
H40.023 | Open angle with borderline findings, high risk, bilateral |
H40.031 | Anatomical narrow angle, right eye |
H40.032 | Anatomical narrow angle, left eye |
H40.033 | Anatomical narrow angle, bilateral |
H40.041 | Steroid responder, right eye |
H40.042 | Steroid responder, left eye |
H40.043 | Steroid responder, bilateral |
H40.051 | Ocular hypertension, right eye |
H40.052 | Ocular hypertension, left eye |
H40.053 | Ocular hypertension, bilateral |
H40.061 | Primary angle closure without glaucoma damage, right eye |
H40.062 | Primary angle closure without glaucoma damage, left eye |
H40.063 | Primary angle closure without glaucoma damage, bilateral |
H40.10X0 - H40.63X4 | Unspecified open-angle glaucoma, stage unspecified - Glaucoma secondary to drugs, bilateral, indeterminate stage |
H40.811 - H40.9 | Glaucoma with increased episcleral venous pressure, right eye - Unspecified glaucoma |
H42 | Glaucoma in diseases classified elsewhere |
H44.001 - H44.23 | Unspecified purulent endophthalmitis, right eye - Degenerative myopia, bilateral |
H44.2A1 - H44.2E9 | Degenerative myopia with choroidal neovascularization, right eye - Degenerative myopia with other maculopathy, unspecified eye |
H44.30 - H44.9 | Unspecified degenerative disorder of globe - Unspecified disorder of globe |
H46.00 - H47.9 | Optic papillitis, unspecified eye - Unspecified disorder of visual pathways |
H49.00 - H51.9 | Third [oculomotor] nerve palsy, unspecified eye - Unspecified disorder of binocular movement |
H53.001 - H53.9 | Unspecified amblyopia, right eye - Unspecified visual disturbance |
H54.0X33 - H54.0X55 | Blindness right eye category 3, blindness left eye category 3 - Blindness right eye category 5, blindness left eye category 5 |
H54.10 - H54.1225 | Blindness, one eye, low vision other eye, unspecified eyes - Low vision right eye category 2, blindness left eye category 5 |
H54.2X11 - H54.2X22 | Low vision right eye category 1, low vision left eye category 1 - Low vision right eye category 2, low vision left eye category 2 |
H54.3 - H54.40 | Unqualified visual loss, both eyes - Blindness, one eye, unspecified eye |
H54.413A - H54.415A | Blindness right eye category 3, normal vision left eye - Blindness right eye category 5, normal vision left eye |
H54.42A3 - H54.42A5 | Blindness left eye category 3, normal vision right eye - Blindness left eye category 5, normal vision right eye |
H54.50 | Low vision, one eye, unspecified eye |
H54.511A - H54.512A | Low vision right eye category 1, normal vision left eye - Low vision right eye category 2, normal vision left eye |
H54.52A1 - H54.52A2 | Low vision left eye category 1, normal vision right eye - Low vision left eye category 2, normal vision right eye |
H54.60 - H54.8 | Unqualified visual loss, one eye, unspecified - Legal blindness, as defined in USA |
H55.00 - H55.89 | Unspecified nystagmus - Other irregular eye movements |
H57.8 | Other specified disorders of eye and adnexa |
I61.0 - I66.9 | Nontraumatic intracerebral hemorrhage in hemisphere, subcortical - Occlusion and stenosis of unspecified cerebral artery |
I67.1 - I67.2 | Cerebral aneurysm, nonruptured - Cerebral atherosclerosis |
I67.4 - I67.82 | Hypertensive encephalopathy - Cerebral ischemia |
I67.841 - I68.8 | Reversible cerebrovascular vasoconstriction syndrome - Other cerebrovascular disorders in diseases classified elsewhere |
M31.5 - M31.6 | Giant cell arteritis with polymyalgia rheumatica - Other giant cell arteritis |
Q10.0 - Q10.7 | Congenital ptosis - Congenital malformation of orbit |
Q14.0 - Q14.9 | Congenital malformation of vitreous humor - Congenital malformation of posterior segment of eye, unspecified |
Q15.0 | Congenital glaucoma |
Q85.00 | Neurofibromatosis, unspecified |
Q85.03 | Schwannomatosis |
Q85.09 | Other neurofibromatosis |
R44.1 | Visual hallucinations |
R48.3 | Visual agnosia |
S00.10XA - S00.12XS | Contusion of unspecified eyelid and periocular area, initial encounter - Contusion of left eyelid and periocular area, sequela |
S04.019A - S04.019S | Injury of optic nerve, unspecified eye, initial encounter - Injury of optic nerve, unspecified eye, sequela |
S04.02XA - S04.02XS | Injury of optic chiasm, initial encounter - Injury of optic chiasm, sequela |
S04.031A - S04.039S | Injury of optic tract and pathways, right side, initial encounter - Injury of optic tract and pathways, unspecified side, sequela |
S04.041A - S04.049S | Injury of visual cortex, right side, initial encounter - Injury of visual cortex, unspecified side, sequela |
S04.10XA - S04.12XS | Injury of oculomotor nerve, unspecified side, initial encounter - Injury of oculomotor nerve, left side, sequela |
S04.20XA - S04.20XS | Injury of trochlear nerve, unspecified side, initial encounter - Injury of trochlear nerve, unspecified side, sequela |
S05.10XA - S05.12XS | Contusion of eyeball and orbital tissues, unspecified eye, initial encounter - Contusion of eyeball and orbital tissues, left eye, sequela |
S05.90XA - S05.90XS | Unspecified injury of unspecified eye and orbit, initial encounter - Unspecified injury of unspecified eye and orbit, sequela |
T15.00XA - T15.92XS | Foreign body in cornea, unspecified eye, initial encounter - Foreign body on external eye, part unspecified, left eye, sequela |
Z09 | Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm |
Z79.3 | Long term (current) use of hormonal contraceptives |
Z79.891 | Long term (current) use of opiate analgesic |
Z79.899 | Other long term (current) drug therapy |
Medical record documentation should indicate the medical necessity for performing the test. In addition, documentation that the service was performed including the results of the visual field examination should be available. This information is normally found in the office notes, progress notes, history and physical, and/or hard copy of the test results.
If the provider of the service is other than the ordering/referring physician, the provider of the service should maintain hard copy documentation of test results and maintain hard copy documentation of test results and interpretation along with copies of the ordering/referring physician’s order for the studies. The physician should state the clinical indication/medical necessity for the study in this order for the test.
1. Report a visual field examination with extended intensity with CPT code 92083. This is a bilateral test, therefore no modifiers are required if both eyes are examined. A unit of “1” is placed in the unit field of the CMS 1500 form or its electronic equivalent.
2. Gross visual field testing (e.g. confrontation testing) is part of the ophthalmological examination and should not be reported separately.
3. A visual field test requires general supervision by the optometrist/ophthalmologist.
4. An eye examination may be reported on the same day as a visual field test if it is medically necessary.
It is expected that these services would be performed as indicated by current medical literature and/or standards of practice. When services are performed in excess of established parameters, they may be subject to review for medical necessity.